Shopping Cart
- Remove All
- Your shopping cart is currently empty
Anti-Phospho-NFKBIA (Ser32) Polyclonal Antibody is a Rabbit antibody targeting Phospho-NFKBIA (Ser32). Anti-Phospho-NFKBIA (Ser32) Polyclonal Antibody can be used in WB.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
50 μL | $218 | 7-10 days | |
100 μL | $316 | 7-10 days |
Description | Anti-Phospho-NFKBIA (Ser32) Polyclonal Antibody is a Rabbit antibody targeting Phospho-NFKBIA (Ser32). Anti-Phospho-NFKBIA (Ser32) Polyclonal Antibody can be used in WB. |
Alias | p-NFKBIA (Ser32), p-NFKBIA (S32), NFKBIA (p-Ser32), NFKBIA (p-S32) |
Ig Type | IgG |
Reactivity | Human,Mouse,Rat |
Application | |
Recommended Dose | WB: 1:1000-2000 |
Antibody Type | Polyclonal |
Host Species | Rabbit |
Construction | Polyclonal Antibody |
Purification | The antibody was affinity-purified from rabbit serum by affinity-chromatography using specific immunogen. |
Appearance | Liquid |
Formulation | Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
Research Background | NFKB inhibitor alpha(NFKBIA) Homo sapiens This gene encodes a member of the NF-kappa-B inhibitor family, which contain multiple ankrin repeat domains. The encoded protein interacts with REL dimers to inhibit NF-kappa-B/REL complexes which are involved in inflammatory responses. The encoded protein moves between the cytoplasm and the nucleus via a nuclear localization signal and CRM1-mediated nuclear export. Mutations in this gene have been found in ectodermal dysplasia anhidrotic with T-cell immunodeficiency autosomal dominant disease. [provided by RefSeq, Aug 2011], |
Conjucates | Unconjugated |
Others Formats | Phospho |
Immunogen | A synthesized phosphopeptide: human IκBα around the phosphorylation site of Ser32 |
Antigen Species | human |
Uniprot ID |
Molecular Weight | Actual: 39 kDa. |
Stability & Storage | Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
Transport | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.